EQT Life Sciences
Portfolio in Germany · Spain: 3 funded startups tracked by Uback, 3 of them in a ranking.
Portfolio on Uback3startups, 2 countries
In a ranking3ranked by AI-estimated valuation
On the Radar0eligible, not ranked
Latest deal trackedOct 2025Tubulis
Portfolio on Uback
Sorted by Uback rank, then Radar by last round| Company | Uback | Sector | Round backed | Valuation (AI) |
|---|---|---|---|---|
| SpliceBio | #11 Spain | Biotech › gene therapy (ophthalmology) | Series B · USD 135M (EUR 118M) · Jun 2025 | Hundreds of M$ |
| Tubulis | #17 Germany | Biotech › antibody-drug conjugates | Series C · EUR 308M (USD 361M) · Oct 2025 | Unicorn |
| SciRhom | #50 Germany | Biotech › antibodies for autoimmune disease | Series A · EUR 63M (USD 70M) · Jul 2024 | Hundreds of M$ |
Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.
By sector
Deals tracked per year
12024
22025
Co-investors
Sanofi Ventures · Roche Venture Fund · Venrock · Wellington Management · Nextech · Andera
Investors that joined the same rounds, as reported by public sources.
Last updated: Oct 2026Report a missing dealReport an error
Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.